TradingView
RocketTickers
2018年8月14日下午4點50分

Motif Bio Announces FDA Acceptance of New Drug Application with  看多

NASDAQ:MTFB1D

描述

⋅
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Beyond Technical Analysis
更多